Evolving from COVID-19

Oncology clinical trial trends that matter


Sarah Rose Anderson | Emile Youssef, MD, PhD | Clare Wallis | Wioletta Laszczewska, MD, PhD | Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM

Hear the unique perspective of Worldwide’s oncology experts about the evolution of clinical trials due to COVID-19 and why those changes matter.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Sarah Rose Anderson
MEET THE AUTHOR

Sarah Rose Anderson

Executive Director, Oncology, Therapeutic Strategy Lead, Business Development
LEARN MORE
Emile Youssef, MD, PhD
MEET THE AUTHOR

Emile Youssef, MD, PhD

Vice President, Oncology Scientific Solutions
LEARN MORE
Clare Wallis
MEET THE AUTHOR

Clare Wallis

Senior Vice President, Project Management
LEARN MORE
Wioletta Laszczewska, MD, PhD
MEET THE AUTHOR

Wioletta Laszczewska, MD, PhD

Senior Medical Director, Medical Affairs
LEARN MORE
Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM
MEET THE AUTHOR

Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM

Senior Medical Director, Medical Affairs, Oncology
LEARN MORE

RELATED CONTENT